Edit
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Immunohematology Market to reach USD 3.1 billion by 2027.

Global Immunohematology Market Size study, by Product (Immunohematology analyzer, Immunohematology reagent), by End-User (Hospitals, Blood Banks, Diagnostic Laboratories) and Regional Forecasts 2020-2027

Product Code: HALMDAE_40431269
Publish Date: 24-09-2020
Page: 200

Global Immunohematology Market is valued approximately at USD 2.0 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 5.6% over the forecast period 2020-2027. Immunohematology is a division of hematology and transfusion medicine that studies antigen-antibody reactions and analogous phenomena since they correlate to the pathogenesis and clinical indications of blood disorders. Immunohematology helps in the diagnosis of blood antigens, white blood cell, Rh factor, and plasma components in the donor blood. It is commonly known as blood banking, that deals with creation of blood elements for transfusion. It often facilitates in reduction of transfusion-associated fatalities, such as HIV and thalassemia. Moreover, the advent of next-generation immunohematology devices often helps clinicians to improve the effectiveness of emergency support to patients. It can lead to introduce more advanced features in immunohematology devices that can meet certain requirements of end-users. Therefore, this factor may drive the demand for immunohematology market. Moreover, the rise in prevalence of HIV and other target diseases, along with increasing investment by public and private organization in blood banks are the few factors responsible for the CAGR of the market during the forecast period. According to the Joint United Nations Programme on HIV and AIDS (UNAIDS), in 2019, nearly 1.7 million individuals were newly affected by HIV, compared to a 2.8 million adult population in 1998. This, in turn, is likely to strengthen the demand for Immunohematology, thereby contributing to the market growth around the world. However, the high cost and lack of awareness regarding the product is one of the prime factors restraining the market growth over the forecast period of 2020-2027.

The regional analysis of the global Immunohematology market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising government support to for blood transfusion, along with the significant presence of market vendors in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the increasing awareness concerning genetic testing for blood disorders coupled with growing prevalence of target diseases in the developing nations, such as China and India, are the few factors creating a lucrative opportunity for the growth of the Immunohematology market in the Asia-Pacific region.

Major market player included in this report are:
Bio-Rad Laboratories, Inc.
Immucor, Inc.
Grifols, S.A.
Becton, Dickinson and Company
Hologic, Inc.
Siemens Healthcare GmbH
Thermo Fisher Scientific
Abbott Laboratories
Beckman Coulter Inc.
Roche Diagnostics Corp.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Immunohematology analyzer
Immunohematology reagent

By End-User:
Hospitals
Blood Banks
Diagnostic Laboratories

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Immunohematology Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Immunohematology Market, by Region, 2018-2027 (USD Billion)
1.2.2. Immunohematology Market, by Product, 2018-2027 (USD Billion)
1.2.3. Immunohematology Market, by End-User, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Immunohematology Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Immunohematology Market Dynamics
3.1. Immunohematology Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Immunohematology Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Immunohematology Market, by Product
5.1. Market Snapshot
5.2. Global Immunohematology Market by Product, Performance – Potential Analysis
5.3. Global Immunohematology Market Estimates & Forecasts by Product 2017-2027 (USD Billion)
5.4. Immunohematology Market, Sub Segment Analysis
5.4.1. Immunohematology analyser
5.4.2. Immunohematology reagent
Chapter 6. Global Immunohematology Market, by End-User
6.1. Market Snapshot
6.2. Global Immunohematology Market by End-User, Performance – Potential Analysis
6.3. Global Immunohematology Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
6.4. Immunohematology Market, Sub Segment Analysis
6.4.1. Hospitals
6.4.2. Blood Banks
6.4.3. Diagnostic Laboratories
Chapter 7. Global Immunohematology Market, Regional Analysis
7.1. Immunohematology Market, Regional Market Snapshot
7.2. North America Immunohematology Market
7.2.1. U.S. Immunohematology Market
7.2.1.1. Product breakdown estimates & forecasts, 2017-2027
7.2.1.2. End-User breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Immunohematology Market
7.3. Europe Immunohematology Market Snapshot
7.3.1. U.K. Immunohematology Market
7.3.2. Germany Immunohematology Market
7.3.3. France Immunohematology Market
7.3.4. Spain Immunohematology Market
7.3.5. Italy Immunohematology Market
7.3.6. Rest of Europe Immunohematology Market
7.4. Asia-Pacific Immunohematology Market Snapshot
7.4.1. China Immunohematology Market
7.4.2. India Immunohematology Market
7.4.3. Japan Immunohematology Market
7.4.4. Australia Immunohematology Market
7.4.5. South Korea Immunohematology Market
7.4.6. Rest of Asia Pacific Immunohematology Market
7.5. Latin America Immunohematology Market Snapshot
7.5.1. Brazil Immunohematology Market
7.5.2. Mexico Immunohematology Market
7.6. Rest of The World Immunohematology Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Bio-Rad Laboratories, Inc.
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Immucor, Inc.
8.2.3. Grifols, S.A.
8.2.4. Becton, Dickinson and Company
8.2.5. Hologic, Inc.
8.2.6. Siemens Healthcare GmbH
8.2.7. Thermo Fisher Scientific
8.2.8. Abbott Laboratories
8.2.9. Beckman Coulter Inc.
8.2.10. Roche Diagnostics Corp.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

The study of the market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geographies to provide a better regional outlook. In the report, country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. Our analysts contact company executives, managers, key opinion leaders, and industry experts. This enables our analyst to derive the closest possible figures without any major deviations in the actual number.

Primary Research Sources:

  • Interview conducted with raw material suppliers & manufacturers.
  • Interview conducted with manufacturers, suppliers & distributors, researchers, & representatives of regulatory bodies.
  • Interview conducted with market players, industry experts, & independent consultants.
  • Secondary Research Sources:
  • Purchased Database: D&B Hoovers, Bloomberg, Inc., Business Information Industry Association, NAICS Association.
  • Internal Database: White papers, Certified Publications, Articles by Recognized Authors and Regulatory Bodies.
  • Government Databases: Food and Agriculture Organization (FAO), European Industrial Hemp Association (EIHA), World Health Organization (WHO), Food and Drug Administration (FDA), International Telecommunication Union (ITU), United States Department of Agriculture (USDA), International organization of Motor Vehicle Manufacturers (OICA).

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now